NCT06884449

A Placebo-Controlled Study Evaluating the Effects of Arrabina on Satiety in Healthy Adults

A Randomized, Double-Blind, Parallel, 3-Arm, Placebo-Controlled Study Evaluating the Effects of Arrabina on Satiety in Healthy Adults

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 135 (actual)
• Sponsor: Comet Bio Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study is being conducted to assess the effects of a prebiotic product, Arrabina, on appetite in healthy adults. The goal is to see if this product can help with appetite regulation, support gut health, and support weight management.

Detailed description

This is a randomized, double-blind, parallel, 3-arm, placebo-controlled study to assess the effects of Arrabina Prebiotic on satiety in healthy adults. The primary goal of this study is to assess how two different doses of Arrabina affect self-reported appetite. Secondary goals include evaluating weight control, eating behaviors, mood, sleep quality, and memory. The product is expected to support beneficial gut bacteria, help maintain lipid levels, and promote digestive comfort and appetite regulation.

Conditions

• Satiety
• Appetite Regulation
• Weight Control

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Arrabina Prebiotic 5.0 g	Active Powder
DIETARY_SUPPLEMENT	Arrabina Prebiotic 3.5 g	Active Powder
OTHER	Placebo	Placebo Powder

Timeline

• Start date: 2025-04-15
• Primary completion: 2025-10-20
• Completion: 2025-10-20
• First posted: 2025-03-19
• Last updated: 2026-02-19

Locations

3 sites across 1 country: United States